Koppers Holdings Inc. Declares Quarterly Cash Dividend
PITTSBURGH, Aug. 7, 2025 /PRNewswire/ -- Koppers Holdings Inc. (NYSE: KOP), an integrated global provider of treated wood products, wood treatment...
Morning Movers
Janus International Group Reports Second Quarter 2025 Financial Results
TEMPLE, Ga.--(BUSINESS WIRE)--Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading provider of building product solutions and...
CORRECTING and REPLACING Backblaze Announces Strong Second Quarter 2025 Financial Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Third bullet under Recent Business Highlights should read: Up-Market Momentum: Customers contributing over $50,000 in ARR grew...
Advantage Solutions Reports Second Quarter 2025 Results
Strong profitability growth in Experiential and Retailer Services Advancing transformation initiatives to accelerate AI enablement and improved business insights Expecting...
WEC Energy Group’s Corporate Responsibility Report highlights sustainable progress for an enduring enterprise
MILWAUKEE , Aug. 7, 2025 /PRNewswire/ -- WEC Energy Group (NYSE: WEC) today released its 2024 Corporate Responsibility Report. The report...
Arhaus Reports Second Quarter 2025 Financial Results
BOSTON HEIGHTS, Ohio, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle...
Skydance Media and Paramount Global Complete Merger, Creating Next Generation Media Company
Ellison Family and RedBird Capital Provide Long-Term Strategic Investment to Reinvigorate Entertainment Powerhouse David Ellison Open Letter Available at www.Paramount.com/news...
Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with Novel PDE4 Inhibitor, PALI-2108
PALI-2108 demonstrated to be safe and well tolerated with no serious adverse events (SAEs) Extended half-life and local bioactivation support...
OS Therapies Announces Statistically Significant Positive Interim 2-Year Overall Survival Data from Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
66.6% of OST-HER2 treated patients achieved 2-year overall survival compared with 40% in the historical control group (p = 0.0046)FDA...
Ball Corporation Announces Public Offering of Senior Notes
WESTMINSTER, Colo., Aug. 7, 2025 /PRNewswire/ -- Ball Corporation ("Ball") (NYSE: BALL) announced today that it has commenced an underwritten...
Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook
Second Quarter Revenue was $589.6 million, a 16.8% increase over the prior year periodSecond Quarter Net income was $27.0 million,...
Arhaus Reports Second Quarter 2025 Financial Results
BOSTON HEIGHTS, Ohio, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle...
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI)...
HanesBrands Inc. Announces Better-Than-Expected Second-Quarter 2025 Results and Raises Full-Year Outlook
WINSTON-SALEM, N.C.--(BUSINESS WIRE)--HanesBrands Inc. (NYSE: HBI), a global leader in everyday iconic apparel, today announced results for the second-quarter 2025.HanesBrands...
GFL Environmental Inc. Announces Agreement to Recapitalize Green Infrastructure Partners at an Enterprise Value of $4.25 Billion with Investment from Energy Capital Partners
VAUGHAN, ON and SUMMIT, N.J., Aug. 7, 2025 /PRNewswire/ - GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) ("GFL" or the...
Sempra Reports Second-Quarter 2025 Results
SAN DIEGO, Aug. 7, 2025 /PRNewswire/ -- Sempra (NYSE: SRE) today reported second-quarter 2025 earnings, prepared in accordance with Generally...
Edgewise Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
– Announced positive top-line data from the open-label extension MESA trial of sevasemten in participants with Becker muscular dystrophy who previously...
Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Haslet, Texas
BIRMINGHAM, Ala., and HASLET, Texas, Aug. 7, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a...
NoHo, Inc. Announces Strategic Growth Initiatives and Corporate Update
LAS VEGAS, Aug. 7, 2025 /PRNewswire/ -- NoHo, Inc. (Stock Symbol: DRNK) ("NoHo" or the "Company") today announced a series...
Encompass Health announces plans to build a 50-bed inpatient rehabilitation hospital in Haslet, Texas
BIRMINGHAM, Ala., and HASLET, Texas, Aug. 7, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced plans to build a...
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next...
OS Therapies Receives Positive Feedback from UK MHRA Scientific Advice Meeting and Submits Innovative Licensing and Access Pathway (ILAP) Request for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
MHRA seeks to harmonize UK & US regulatory review via Project OrbisEMA Rapporteur Scientific Advice Meeting scheduled for October 2025New...
Cars.com Reports Second Quarter 2025 Results
Grew to 19,412 Dealer Customers, Driven by Strong Sequential Increase in Marketplace SubscriptionsAchieved Record First Half 27.8MM Monthly Average Unique...
Nova Reports Record Second Quarter 2025 Financial Results
REHOVOT, Israel , Aug. 7, 2025 /PRNewswire/ -- Nova (Nasdaq: NVMI) today announced financial results for the second quarter, the three-month...
Leatt Corp Announces Results for the Second Quarter 2025
Global revenues increase 61%; Net income increases 208% CAPE TOWN, South Africa, Aug. 7, 2025 /PRNewswire/ -- Leatt Corporation (OTCQB:...
WK Kellogg Co Announces Second Quarter Financial Results
BATTLE CREEK, Mich., Aug. 7, 2025 /PRNewswire/ -- WK Kellogg Co (NYSE: KLG), today published its second quarter 2025 results...
iRobot Reports Second-Quarter 2025 Financial Results
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ -- iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced its financial...
WhiteHorse Finance, Inc. Announces Second Quarter 2025 Earnings Results and Declares Quarterly Distribution of $0.385 Per Share
NEW YORK, Aug. 7, 2025 /PRNewswire/ -- WhiteHorse Finance, Inc. ("WhiteHorse Finance" or the "Company") (Nasdaq: WHF) today announced its financial results...
Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance
Delivers Total Revenues Above Expectations Reflecting the Strength of our Execution and the Resilience of our Diversified Global Business Positive...
Vistra Reports Second Quarter 2025 Results
Earnings Release Highlights GAAP second quarter 2025 Net Income of $327 million and Cash Flow from Operations of $1,171 million....
Starwood Property Trust Reports Results for Quarter Ended June 30, 2025
– Quarterly GAAP Earnings of $0.38 and Distributable Earnings (DE) of $0.43 per Diluted Share – – Invested $3.2 Billion...
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
Management Expects High Demand Driven by Speed, Simplicity, and Clinical Precision Oak Ridge, TN, Aug. 07, 2025 (GLOBE NEWSWIRE) --...
Sabre’s second quarter 2025 earnings materials available on its Investor Relations website
SOUTHLAKE, Texas, Aug. 7, 2025 /PRNewswire/ -- Sabre Corporation ("Sabre") (NASDAQ: SABR) today announced financial results for the quarter ended...
Construction Partners, Inc. Announces Fiscal 2025 Third Quarter Results
Revenue Up 51% Compared to Q3 FY24 Adjusted EBITDA Up 80% Compared to Q3 FY24 Record Backlog of $2.94 Billion...
REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy
A pivotal Phase IIb/III clinical trial using suprachoroidal delivery for treatment of diabetic retinopathy will be initiated New Phase II...
REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights
RGX-202 in Duchenne muscular dystrophy on track for topline results 1H 2026 and BLA submission mid-2026 Pivotal trial enrollment accelerated,...
Crocs, Inc. Reports Solid Second Quarter 2025 Results Led By Both Brands
BROOMFIELD, Colo., Aug. 7, 2025 /PRNewswire/ -- Crocs, Inc. (NASDAQ: CROX), a world leader in innovative casual footwear for all, today...
Nova Reports Record Second Quarter 2025 Financial Results
REHOVOT, Israel , Aug. 7, 2025 /PRNewswire/ -- Nova (Nasdaq: NVMI) today announced financial results for the second quarter, the three-month...
BCE reports second quarter 2025 results
This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section...
Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update
—ARIKAYCE® (amikacin liposome inhalation suspension) Total Revenue of $107.4 Million for the Second Quarter of 2025, Reflecting 19% Growth Over...